InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,388.84
(
0.83%
)
US TECH 100
18,300.40
(
1.36%
)
Dow Jones
39,447.01
(
0.23%
)
Brent Oil
80.77
(
-1.02%
)
Bitcoin
59,455.33
(
0.18%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rocky301

Send PM Follow Ignore
Followers 110
Posts 6480
Boards Moderated 0
Alias Born 05/01/2003

rocky301

Re: louisa post# 22513

Wednesday, 03/03/2010 4:26:08 PM

Wednesday, March 03, 2010 4:26:08 PM

Post# of 92948
louisa,

thanks for the article. This part is key, imo.

"The eventual goal of developing the cells as a treatment for Stargardt's is not just treating the syndrome, says ACT's William Caldwell, but developing similar treatments for blindness-related ailments such as macular degeneration, which afflicts increasing numbers of aging Baby Boomers."
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up